# The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis

Study · id `cardio:ct-nct02254655` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02254655](<https://clinicaltrials.gov/study/NCT02254655>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02254655

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

## Technical summary

Registry record NCT02254655. Randomized; single masking; primary purpose supportive care. Start 2013-11 (actual); primary completion 2017-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose supportive care
- Phase: Phase 2
- Enrolled: 119 participants (enrolled count; ClinicalTrials.gov record NCT02254655, source copy `cardio:ctgov-nct02254655-2018-01-17`, retrieved 2026-10-31)
- Started: 2013-11 (actual) (ClinicalTrials.gov record NCT02254655, source copy `cardio:ctgov-nct02254655-2018-01-17`, retrieved 2026-10-31)
- Primary completion: 2017-09 (actual) (ClinicalTrials.gov record NCT02254655, source copy `cardio:ctgov-nct02254655-2018-01-17`, retrieved 2026-10-31)
- Completion: 2017-11 (actual) (ClinicalTrials.gov record NCT02254655, source copy `cardio:ctgov-nct02254655-2018-01-17`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02254655-2018-01-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis
- Condition: Rheumatoid Arthritis
- Intervention (Drug): Puerarin injection 400 mg
- Intervention (Drug): Control
- Lead sponsor: Chengdu PLA General Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The Effect of Puerarin on Carotid Intima-media Thickness in Patients With Active Rheumatoid Arthritis: ARandomized Controlled Trial (`cardio:pubmed-30245282`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a8682bbfb16bc60f0028d06083fd624bde7adebb1dbc5e50a97690eb47a06e63
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
